Mamoru Takada et al. found that the RFS and overall survival rate (OS) of breast cancer patients with BRCA1 mutation accompanied with PA1 deficiency were significantly lower than those without PA1 deficiency (Takada et al., 2017). Here, PAGR1 is linked to breast cancer.